316 related articles for article (PubMed ID: 29416821)
1. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.
Liu H; Chen L; Peng Y; Yu S; Liu J; Wu L; Zhang L; Wu Q; Chang X; Yu X; Liu T
Oncotarget; 2018 Jan; 9(2):2887-2894. PubMed ID: 29416821
[TBL] [Abstract][Full Text] [Related]
2. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
[TBL] [Abstract][Full Text] [Related]
4. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy using dendritic cell-derived exosomes.
Amigorena S
Medicina (B Aires); 2000; 60 Suppl 2():51-4. PubMed ID: 11188932
[TBL] [Abstract][Full Text] [Related]
7. Exosomes: small vesicles with big roles in hepatocellular carcinoma.
Wu Z; Zeng Q; Cao K; Sun Y
Oncotarget; 2016 Sep; 7(37):60687-60697. PubMed ID: 27463001
[TBL] [Abstract][Full Text] [Related]
8. Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers.
Zheng H; Su N; Yan G; Li M; Chu H; Zhang J; Li B; Zhao J; Wang J; Gao M; Zhang X
Anal Chim Acta; 2024 Jan; 1287():342109. PubMed ID: 38182386
[TBL] [Abstract][Full Text] [Related]
9. Theranostic signature of tumor-derived exosomes in cancer.
Kumar S; Dhar R; Kumar LBSS; Shivji GG; Jayaraj R; Devi A
Med Oncol; 2023 Oct; 40(11):321. PubMed ID: 37798480
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis.
Chen H; Chengalvala V; Hu H; Sun D
Acta Pharm Sin B; 2021 Aug; 11(8):2136-2149. PubMed ID: 34522581
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway.
Shen Y; Guo D; Weng L; Wang S; Ma Z; Yang Y; Wang P; Wang J; Cai Z
Oncoimmunology; 2017; 6(12):e1362527. PubMed ID: 29209566
[TBL] [Abstract][Full Text] [Related]
12. Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer.
Verdi J; Ketabchi N; Noorbakhsh N; Saleh M; Ebrahimi-Barough S; Seyhoun I; Kavianpour M
Curr Stem Cell Res Ther; 2022; 17(1):91-102. PubMed ID: 34161212
[TBL] [Abstract][Full Text] [Related]
13. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
14. The exosomes in tumor immunity.
Liu Y; Gu Y; Cao X
Oncoimmunology; 2015 Sep; 4(9):e1027472. PubMed ID: 26405598
[TBL] [Abstract][Full Text] [Related]
15. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
16. Exosomes in cancer therapy: a novel experimental strategy.
Gao D; Jiang L
Am J Cancer Res; 2018; 8(11):2165-2175. PubMed ID: 30555736
[TBL] [Abstract][Full Text] [Related]
17. The Role of Tumor-Derived Exosomes in the Abscopal Effect and Immunotherapy.
Shan Z; Wang H; Zhang Y; Min W
Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33922480
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
19. Exosomes Isolated from Ascites of T-Cell Lymphoma-Bearing Mice Expressing Surface CD24 and HSP-90 Induce a Tumor-Specific Immune Response.
Menay F; Herschlik L; De Toro J; Cocozza F; Tsacalian R; Gravisaco MJ; Di Sciullo MP; Vendrell A; Waldner CI; Mongini C
Front Immunol; 2017; 8():286. PubMed ID: 28360912
[TBL] [Abstract][Full Text] [Related]
20. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells.
Mallegol J; Van Niel G; Lebreton C; Lepelletier Y; Candalh C; Dugave C; Heath JK; Raposo G; Cerf-Bensussan N; Heyman M
Gastroenterology; 2007 May; 132(5):1866-76. PubMed ID: 17484880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
